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Summary
 
T cell development and selection in the thymus are shaped by the induction of apoptosis.
However, a direct role in T cell development and selection for any of the molecules known to
 
regulate apoptosis has remained controversial. We have studied the effect of 
 
bax
 
 and 
 
bcl-2
 
 trans-
 
genes in recombination activation gene 1–deficient (RAG-1
 
2
 
/
 
2
 
) mice transgenic for the major
histocompatibility complex class I–restricted F5 T cell receptor. Overexpression of a 
 
bax
 
 trans-
gene in the thymus seriously impairs the production of mature T cells, whereas 
 
bcl-2 
 
overex-
pression greatly promotes it. The effect of 
 
bax
 
 and 
 
bcl-2
 
 overexpression on antigen-induced
negative selection was studied using fetal thymic organ cultures. This analysis showed that Bcl-2
strongly inhibits negative selection, whereas Bax does not affect it. Our data directly show
that Bcl-2 family members have specific roles in T cell selection and also lend support to the
hypothesis that Bax and Bcl-2 can antagonize each other’s action in a certain apoptosis pathway
while in another they can be functionally nonreciprocal.
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T
 
he development of T cells in the thymus is character-
ized by the production of large numbers of immature
thymocytes that are then subjected to stringent selection
criteria. Only those thymocytes expressing a TCR capable
of interacting with self-peptides presented by MHC mole-
cules on thymic epithelial cells are positively selected and
exit into the periphery (1–4). However, thymocytes with
receptors that bind to self-peptide–MHC complexes with
high affinity are negatively selected and die (1, 5, 6). Al-
though negative selection of thymocytes has been shown to
be mediated by the induction of apoptosis (7), any direct
role that molecules known to regulate apoptosis play in the
outcome of this process has remained controversial.
Many different molecules that can regulate apoptosis
have now been identified. Of particular interest with re-
gards to T cell development are the members of the Bcl-2
family (for review see reference 8). This family consists of
proteins that enhance cell survival, such as Bcl-2 or Bcl-X
 
L
 
,
and those that promote cell death, such as Bax or Bad. Bax
was isolated by virtue of its interaction with Bcl-2 with
which it forms heterodimers (9). Thymocytes from mice
expressing a 
 
bcl-2
 
 transgene in their T cells are protected
against apoptosis induced by dexamethasone (10, 11). Con-
versely, thymocytes from mice expressing a 
 
bax
 
 transgene
in their T cells show accelerated cell death in response to
treatment with dexamethasone (12). In the thymus the Bcl-2
protein is uniformly expressed in medullary thymocytes
but only in a small fraction of cortical thymocytes (13, 14).
This lack of Bcl-2 correlates with the fact that most cortical
thymocytes undergo programmed cell death. Furthermore,
nearly all CD4
 
1
 
 and CD8
 
1
 
 single positive (SP)
 
1
 
 thymocytes
express Bcl-2, whereas the vast majority of CD4
 
1
 
CD8
 
1
 
double positive (DP) thymocytes do not (15–18). DP thy-
mocytes are the stage of T cell development during which
the processes of positive or negative selection operate.
These observations all serve to suggest that Bcl-2 upregula-
tion in the final steps of thymocyte development may play
a role in T cell selection.
Given that T cell maturation is contingent on positive
and negative selection, efforts have been made to study the
regulation of these processes by Bcl-2 with regard to nega-
tive selection in particular. Initial studies examined the ef-
fect of a 
 
bcl-2
 
 transgene on thymocytes with receptors that
recognize self-superantigens. In some studies, Bcl-2 was
found to inhibit superantigen-mediated deletion of autore-
active thymocytes (11, 19), whereas another study failed to
demonstrate any effect of Bcl-2 on this process (10). Subse-
quently, two further studies sought to address the effect of
Bcl-2 on negative selection using TCR transgenic mice
 
1
 
Abbreviations used in this paper:
 
 7AAD, 7-aminoactinomycin; DP, double
positive; FTOC, fetal thymic organ culture; NP, nucleoprotein; RAG-1,
recombination activation gene 1; SP, single positive.
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also expressing a 
 
bcl-2
 
 transgene (20, 21). Both used mice
transgenic for a TCR reactive with the male self-antigen
H-Y in the context of H-2D
 
b
 
. Recognition of the H-Y
antigen in male TCR transgenic mice of the H-2
 
b
 
 haplo-
type results in the deletion of most DP thymocytes (5).
Strasser et al. (20) found an approximately fourfold increase
in the total number of thymocytes in H-Y TCR 
 
3
 
 
 
bcl-2
 
double transgenic male mice over H-Y TCR male mice
alone. They concluded that Bcl-2 reduces the efficiency of
negative selection. However, Tao et al. (21) reached the
opposite conclusion since although they also found an in-
crease in the total number of thymocytes in double trans-
genic male mice, a large fraction of the surviving DP thy-
mocytes expressed endogenous TCR-
 
a
 
 chains and not the
 
a
 
 chain of the H-Y TCR. This is at variance with Strasser
et al. (20), who showed that in their mice the majority of
surviving thymocytes did express the transgenic H-Y TCR
and that their survival could not be explained by the ex-
pression of endogenous TCR genes.
Further doubt has been cast on the significance of 
 
bcl-2
 
family members in negative selection from work using 
 
bcl-X
 
L
 
transgenic mice (22, 23). Bcl-X
 
L
 
 is a close homologue of
Bcl-2 that has similar protective effects against apoptotic
stimuli (24) and a role in the maturation of T cells as judged
from the block in T cell development found in 
 
bcl-X
 
L
 
2
 
/
 
2
 
chimeric mice (25). T cells from 
 
bcl-X
 
L
 
 transgenic mice are
protected against exposure to a variety of apoptosis-pro-
moting stimuli. However, analysis of superantigen-medi-
ated clonal deletion in 
 
bcl-X
 
L
 
 transgenic mice, as well as
H-Y TCR
 
 3 
 
bcl-X
 
L
 
 double transgenic male mice, suggests
that Bcl-X
 
L
 
 has no effect on negative selection (22, 23, 26).
We sought to clarify the role of 
 
bcl-2
 
 family members in
thymic negative selection by studying the effects of 
 
bcl-2
 
and 
 
bax
 
 transgenes on peptide-induced negative selection
in fetal thymic organ culture (FTOC). The FTOCs were
derived from mice transgenic for the F5 TCR (27, 28),
which recognizes an influenza virus nucleoprotein (NP)-
derived nonamer peptide (NP68) in the context of MHC
class I H-2D
 
b
 
 (29). To exclude any effects due to endoge-
nous TCR rearrangements, the mice used were also defi-
cient for the recombination activation gene 1 (RAG-1).
Negative selection of immature thymocytes in the FTOC
was induced by addition of the cognate peptide and di-
rectly quantitated by measuring DNA fragmentation in the
thymocytes. This approach has the advantage of allowing
the direct quantitation of antigen-induced negative selec-
tion in isolation from other thymic selection events, effects
on cell survival, and peripheral T cell activation.
Our study has shown that the apoptotic regulatory mole-
cules Bax and Bcl-2 can have profound effects upon the se-
lection of mature T cells bearing a single TCR. Bax im-
pairs the production of mature SP T cells, whereas Bcl-2
enhances their production. We have also shown that Bcl-2
strongly inhibits negative selection, whereas Bax has no ef-
fect on this process. Therefore, for the first time we directly
show that Bcl-2 can inhibit antigen-mediated negative se-
lection and that Bax and Bcl-2 can be functionally nonre-
ciprocal, as suggested by recent genetic studies (30).
 
Materials and Methods
 
Mice.
 
The F5 RAG-1
 
2
 
/
 
2
 
 mice with the 
 
bax
 
 or 
 
bcl-2
 
 trans-
genes were generated by serial crossing of F5 TCR transgenics,
RAG-1
 
2
 
/
 
2
 
 mice, and 
 
bax
 
 or 
 
bcl-2
 
 transgenics. The mice transgenic
for the 
 
ab
 
-TCR from the F5 cytotoxic T cell clone were gener-
ated as previously reported (28). Mice deficient in the RAG-1 gene
were obtained from Dr. Eugenia Spanopoulou (31). The 
 
bax
 
 trans-
genic mice were as described previously (12) and the bcl-2 trans-
genics were as also previously described (32). Breedings were done
so as to obtain F5 RAG-1
 
2
 
/
 
2
 
 mice with 
 
bax
 
 or 
 
bcl-2
 
 transgenes and
homozygous for either MHC class I H-2
 
b
 
 or H-2
 
q
 
 after backcross-
ing with inbred C57 BL/10 mice for H-2
 
b
 
 and inbred SWR for
H-2
 
q
 
. Antibodies specific for H-2
 
b 
 
and H-2
 
q 
 
were used to deter-
mine the MHC haplotypes present. The genotyping of mice for
the F5 TCR, 
 
bax
 
 or 
 
bcl-2
 
 transgenes and the presence of the
RAG-1 gene was done by either Southern analysis or PCR.
 
Reagents and Antibodies.
 
The nonamer peptide NP68, from
the nucleoprotein of influenza virus A/NT/60/68 (NP366-374:
amino acid sequence, ASNENMDAM), was synthesized on a pep-
tide synthesizer (Applied Biosystems 430A; PE Applied Biosystems,
Foster, CA). The dexamethasone used was purchased from Sigma
Chemical Co. and anti-CD95 (anti-Fas) (Jo2) was purchased from
PharMingen (San Diego, CA). The following mAbs and second
layer reagents were used for flow cytometric analysis: FITC-conju-
gated YTS169.4 (anti-CD8
 
a
 
; reference 33), FITC-conjugated
anti-mouse MHC class I H-2
 
q 
 
(PharMingen), phycoerythrin con-
jugated anti-CD4 (Sigma Chemical Co., St. Louis, MO), biotin
conjugated anti-mouse MHC class I H-2
 
b 
 
(PharMingen), biotin
conjugated KT11 (anti-V
 
b
 
11; reference 34), biotin conjugated
anti-CD69 (PharMingen), and streptavidin-RED 670 (GIBCO
BRL, Gaithersburg, MD).
 
Fetal Thymic Organ Culture.
 
Fetal thymic lobes were isolated
from day 15 embryos, obtained from timed matings of homozy-
gous F5/RAG-1
 
2
 
/
 
2
 
 females with RAG-1
 
2
 
/
 
2
 
 male mice het-
erozygous for the 
 
bax
 
 or 
 
bcl-2
 
 transgene. The presence of the 
 
bax
 
/
 
bcl-2
 
 transgene was determined by PCR analysis on DNA isolated
from each individual embryo. The fetal thymic lobes were trans-
ferred onto nucleopore polycarbonate filters (Costar Corpora-
tion, Cambridge, MA) and cultured at 37
 
8
 
C, 5% CO
 
2
 
 in RPMI
1640 (GIBCO BRL) supplemented with 10% heat-inactivated
FCS, 2 mM 
 
L
 
-glutamine and antibiotics. After 4 d, the filters
were transferred to medium alone or containing 10 
 
m
 
M NP68
peptide, 0.5 
 
m
 
M dexamethasone, or 1 
 
m
 
g/ml anti-CD95 (Jo2)
antibody and cultured for 11 h. Thymocytes were then harvested
for analysis by gently disrupting the thymic lobes mechanically in
1.5-ml Eppendorf tubes.
 
Flow Cytometry.
 
For flow cytometric analysis, 1–5 
 
3
 
 10
 
5
 
 cells
were stained with various combinations of mAbs in PBS contain-
ing 1% BSA (Sigma Chemical Co.) and 0.1% sodium azide. For
analysis of DNA content, cells were stained with 7-aminoactino-
mycin D (7AAD; Sigma Chemical Co.) in PBS containing 0.3%
saponin (Sigma Chemical Co.), 2% FCS, and 0.1% sodium azide.
Stained cells were analyzed on a FACScan
 
Ò
 
 flow cytometer (Bec-
ton Dickinson, Mountain View, CA) using Cellquest software
(Becton Dickinson).
 
Results
 
Effects of Bax on T Cell Development.
 
To definitively study
the effects of apoptosis regulatory molecules on T cell de-
velopment we generated mice having either a 
 
bax
 
 (12) or a
 
bcl-2
 
 (32) transgene, an F5 TCR transgene (27) on a RAG- 
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1
 
2
 
/
 
2
 
 background (31), as well as being homozygous for the
selecting H-2
 
b
 
 or nonselecting H-2
 
q
 
 MHC haplotypes.
These mice remove all problems of interpretation due to
endogenous TCR rearrangements since all the DP and SP
thymocytes in these mice express only the F5 TCR.
First, we studied F5/RAG-1
 
2
 
/
 
2
 
/
 
bax
 
 transgenics on the
H-2
 
b/b
 
 background. As shown in Fig. 1 and Table 1, up-
regulated 
 
bax
 
 expression causes a dramatic decrease in total
thymus cellularity as well as mature SP T cell production.
Thymocytes were analyzed by three-color flow cytometry
with antibodies against CD4, CD8, and V
 
b
 
11 (recognizing
the F5 TCR-
 
b
 
 chain) or CD69 (Fig. 1). The presence of
 
bax
 
 in the F5/RAG-1
 
2
 
/
 
2
 
 mice results in a fall in total thy-
mocyte numbers from 1.90 
 
3
 
 10
 
8
 
 to 0.39 
 
3
 
 10
 
8
 
 and de-
creases CD4
 
2
 
CD8
 
hi
 
 cell numbers more than sixfold from
1.26 
 
3
 
 10
 
7
 
 to 0.20 
 
3
 
 10
 
7 (Table 1). This is also reflected in
a fall in the percentage of CD8 SP (CD42CD8hi) cells pro-
duced (Fig. 1). In the thymus of F5/RAG-12/2 mice, TCR
expression is upregulated (Vb11hi) during the transition
from CD4hiCD8hi, through CD4loCD8hi, to CD42CD8hi
thymocytes, as shown by the shaded region in Fig. 1. How-
ever, the presence of the bax transgene greatly diminishes this
upregulation, particularly in the transitional CD4loCD8hi
population, though even in the CD4hiCD8hi DP thymocytes
the small proportion of Vb11hi cells is lost. A reduced level
of Vb11 expression on CD42CD8hi is also found on the
bax transgenic mice. The observed transient upregulation
of CD69 (35, 36), as thymocytes pass through the CD4lo
CD8hi compartment, is almost completely abolished in F5/
RAG-12/2 mice expressing the bax transgene (Fig. 1).
To determine whether the reduction in total thymocyte
numbers in F5/RAG-12/2/bax mice was dependent on
Figure 1. Flow cytometric analysis of T cell development in the thy-
mus of F5/RAG-12/2/bax H-2b/b mice and littermate controls lacking
the bax transgene. Thymocytes were isolated from F5/RAG-12/2/bax
H-2b/b mice with or without the bax transgene then stained for CD4
(PE), CD8 (FITC), and either Vb11 or CD69 (both biotinylated). (A)
Dot plots of CD4- and CD8-stained thymocytes with gates on the
CD4hiCD8hi, CD4loCD8hi, and CD42CD8hi populations. The numbers
represent the percentage of the total number of thymocytes in each gate.
(B) Histograms represent Vb11 or CD69 expression on the thymocytes in
each gate. The shaded region represents F5/RAG-12/2 mice, whereas
the black line represents the same mice plus the bax transgene.
Figure 2. Flow cytometric analysis of T cell development in the thy-
mus of F5/RAG-12/2/bcl-2 H-2b/b mice and littermate controls lacking
the bcl-2 transgene. Thymocytes were isolated from F5/RAG-12/2/bcl-2
H-2b/b mice with or without the bcl-2 transgene then stained for CD4,
CD8, and either Vb11 or CD69. (A) Dot plots of CD4- and CD8-stained
thymocytes with gates on the CD4hiCD8hi, CD4loCD8hi, and CD42
CD8hi populations. The numbers represent the percentage of the total
number of thymocytes in each gate. (B) Histograms represent Vb11 or
CD69 expression on the thymocytes in each gate. The shaded region rep-
resents F5/RAG-12/2 mice, whereas the black line represents the same
mice plus the bcl-2 transgene.1128 Action of Bax and Bcl-2 on T Cell Selection
tion of mature SP T cells. The bcl-2 transgene in F5/RAG-
12/2/H-2b/b mice results in a more than fourfold increase
in the total number of CD42CD8hi cells from 2.64 3 107
to 11.37 3 107 (Table 2). Table 2 also shows that the pres-
ence of bcl-2 increases the total number of thymocytes from
2.48 3 108 to 4.98 3 108. The bcl-2 transgene also leads to
a greater than twofold increase in the percentage of CD8
SP (CD42CD8hi) thymocytes produced (Fig. 2).
In contrast to bax transgenic mice, the bcl-2 transgene
leads to enhanced upregulation of TCR and CD69 expres-
sion during T cell development (Fig. 2). A higher percent-
age of CD4hiCD8hi cells in the bcl-2 transgenic mice have
high levels of Vb11 and CD69 expression. Similarly, vir-
tually all the CD4loCD8hi thymocytes are Vb11hi and
CD69hi in the bcl-2 transgenic mice as opposed to the
control F5/RAG-12/2 mice. However, mature T cells in
both control and bcl-2 transgenic mice express similar levels
of the F5 TCR.
The effect of the bcl-2 transgene was also determined on
the nonselecting H-2q MHC haplotype. The total number
of thymocytes was increased in the F5/RAG-12/2/bcl-2
transgenic mice from 1.78 3 108 to 3.60 3 108 (Table 2).
Bcl-2 can thus increase the survival of DP thymocytes even
in the absence of positive selection. However, Bcl-2 also
increases the number of mature SP T cells produced when
Table 1. Effect of bax Transgene and MHC on Thymocyte Number in F5/RAG-12/2 Mice
F5/RAG-12/2 H-2b/b F5/RAG-12/2 H-2q/q
2bax 1bax 2bax 1bax
Total thymocytes 1.90 6 0.32 0.39 6 0.14 2.03 6 0.40 0.80 6 0.16
3108 n 5 6 n 5 6 n 5 4 n 5 4
CD8 SP thymocytes 1.26 6 0.25 0.20 6 0.11 — —
3107 n 5 6 n 5 6
Total thymocyte numbers were calculated for age-matched and gender-matched littermates with or without the bax transgene. The total number of
CD8 SP thymocytes was determined after FACSÒ analysis after staining with CD4 and CD8 antibodies. The values represent the mean of four or six
(n) mice and the errors represent their standard deviation.
the presence of selecting MHC molecules we crossed these
mice onto the H-2q/q background. The H-2q MHC haplo-
type is nonselecting for the F5 TCR and T cell develop-
ment is blocked at the DP thymocyte stage in F5/RAG-
12/2/H-2q/q mice (37). The total number of thymocytes in
F5/RAG-12/2/H-2q/q mice was reduced from 2.03 3 108
to 0.80 3 108 in the presence of the bax transgene (Table
1) showing that bax has an effect on the survival of thy-
mocytes, which is independent of thymocyte selection.
Therefore, bax decreases the survival of thymocytes in
the absence of positive selection and also has a direct effect
on the selection of mature T cells expressing the MHC
class I–restricted F5 TCR. The bax transgene leads to a
great reduction in the expression levels of molecules (TCR
and CD69) usually upregulated during positive selection
and a substantial decrease in the number of mature T cells
produced. We conclude that bax can directly affect the
process of T cell selection.
Effects of Bcl-2 on T Cell Development. Our next ques-
tion was to determine whether Bcl-2 could act in the op-
posite fashion to Bax and thus enhance T cell selection.
Therefore, we examined the effect of a bcl-2 transgene on
F5/RAG-12/2 mice with either the H-2b/b or H-2q/q
MHC background. As seen in Fig. 2 and Table 2, upregu-
lated bcl-2 expression has a profound effect on the produc-
Table 2. Effect of bcl-2 Transgene and MHC on Thymocyte Number in F5/RAG-12/2 Mice
F5/RAG-12/2 H-2b/b F5/RAG-12/2 H-2q/q
2bcl-2 1bcl-2 2bcl-2 1bcl-2
Total thymocytes 2.48 6 0.36 4.98 6 1.15 1.78 6 0.22 3.60 6 0.52
3108 n 5 4 n 5 4 n 5 4 n 5 4
CD8 SP thymocytes 2.64 6 0.65 11.37 6 2.18 — —
3107 n 5 4 n 5 4
Total thymocyte numbers were calculated for age-matched and gender-matched littermates with or without the bcl-2 transgene.The total number of
CD8 SP thymocytes was determined following FACSÒ analysis after staining with CD4 and CD8 antibodies. The values represent the mean of four
or six (n) mice and the errors represent their standard deviation.1129 Williams et al.
positive selection does take place, in mice of the H-2b MHC
haplotype. This latter effect is associated with elevated levels
of TCR and CD69 expression during T cell development.
Thus, bcl-2 can directly affect the process of T selection.
Since thymocyte selection involves both positive and nega-
tive selection, the question arises whether Bax and Bcl-2 are
affecting either or both of these processes. To address this,
we analyzed the effect of these molecules on negative selec-
tion in isolation from other thymic selection events.
Direct Quantification of Negative Selection. As described
above, previous studies have provided contradictory evi-
dence as to the influence of Bcl-2 on negative selection.
We wanted to unambiguously determine the role of apop-
totic regulatory molecules such as Bax and Bcl-2 on nega-
tive selection so we chose to study negative selection in
FTOC. The use of FTOCs to study antigen-induced nega-
tive selection has been previously described (38). We have
modified this system in order to directly quantitate the ex-
tent of apoptosis induced in DP thymocytes after acute ex-
posure to antigenic peptide or other apoptotic stimuli. Fetal
thymic lobes from F5/RAG-12/2 mice, with bax or bcl-2
transgenes, were taken at day 15 of gestation. The geno-
type of the thymic lobes was determined by PCR analysis
of DNA from the individual embryos from which they
originated. Thymic lobes were cultured for 4 d in vitro, af-
ter which the apoptotic stimuli were added to the cultures
and 11 h later the percentage of DP thymocytes undergo-
ing apoptosis was determined (Fig. 3).
Since at this stage of the culture most of the thymocytes
have differentiated into immature DP cells, the FTOC en-
abled us to analyze responses of DP thymocytes at early
stages of thymic differentiation. Administration of antigen
to adult TCR transgenic mice leads to thymocyte apoptosis
as an indirect result of mature T cell activation as well as
recognition of the antigenic peptide by the thymocytes
themselves (39, 40). At day 4 of culture the thymic lobes
were virtually devoid of mature T cells, therefore, apopto-
sis of thymocytes was solely due to recognition of the anti-
Figure 3. Direct measurement
of the level of apoptosis caused
by antigen induced negative se-
lection in fetal thymic organ cul-
ture. FTOCs from F5/RAG-12/2
mice with or without the bax or
bcl-2 transgene were cultured for
4 d in vitro. 10 mM NP68 pep-
tide, the cognate antigen for the
F5 TCR, was then added to the
culture. 11 h later the FTOCs
were harvested and stained for
CD4 and CD8 expression as well
as 7AAD to determine DNA
content. (A) Dot plots show
CD4 and CD8 expression on
single cell suspensions of thy-
mocytes from F5/RAG-12/2
mice–derived FTOCs with or
without  bcl-2 transgene, with or
without addition of the NP68
peptide. Histograms show the
DNA content of the DP thy-
mocytes as determined by 7AAD
staining. The marker and accom-
panying figure indicate the per-
centage of hypodiploid DNA
and hence, give a direct measure
of the level of apoptosis in each
sample. (B) The dot plots and
histograms refer to FTOCs from
F5/RAG-12/2 mice with or
without the bax transgene.1130 Action of Bax and Bcl-2 on T Cell Selection
genic peptide. Although FTOCs are performed in vitro,
they create the possibility to analyze the responses of thy-
mocytes in an intact thymic microenvironment, which is
lost in suspension culture systems (41, 42). Another impor-
tant benefit of the FTOC approach is that we can discard
the contribution of survival effects on thymocyte viability
in culture to the overall level of apoptosis. The differenti-
ated FTOCs are grown under optimal conditions in vitro
and show very low levels (,1%) of apoptosis, regardless of
the expression of the bax or bcl-2 transgenes. Therefore, the
levels of apoptosis found are directly due to the stimuli and
the influence of bax or bcl-2 on the pathways they invoke
and not to factors associated with culture conditions. Thus,
we compared thymocyte apoptosis due to antigen, dexa-
methasone, and treatment with anti-CD95 (anti-Fas) anti-
body, and the influence of Bax and Bcl-2 in each of these
apoptotic pathways.
Bax and Negative Selection. First, we examined negative
selection in FTOCs generated from F5/RAG-12/2 H-2b/b
mice with or without the bax transgene. Thymocyte apop-
tosis was examined in response to NP68 (antigenic peptide)
as well as dexamethasone and anti-CD95 antibody (Jo2).
As illustrated in Fig. 3, after staining with 7AAD as well as
anti-CD4 and CD8, FACSÒ was used to determine the
percentage of DP thymocytes containing hypodiploid DNA
and thus undergoing apoptosis. To obtain statistically sig-
nificant results, four to six individual lobes were assayed for
each value shown in Fig. 4. These experiments were re-
peated on four independent occasions and similar data were
obtained each time. After negative selection induced by
NP68, the level of apoptosis in F5/RAG-12/2/bax FTOCs
was not higher than those from the FTOCs without bax
transgene, in fact it was slightly reduced. The level of
NP68 induced apoptosis in bax FTOCs was also examined
at 4 and 6 h to confirm that no effect was detectable at ear-
lier time points in the culture (data not shown). However,
the thymocytes of bax FTOCs show significantly higher
apoptosis than non-bax FTOCs after incubation with dex-
amethasone (Fig. 4) as previously seen in primary thy-
mocytes from bax transgenics (12). The bax transgene has
no significant effect on CD95-induced apoptosis, which
also accords with previous data from primary bax thy-
mocytes (43). We conclude that the bax transgene can act
in FTOCs to increase apoptosis in response to dexametha-
sone but that in the case of cognate antigen induced nega-
tive selection it has no effect. This suggests that Bax has no
role in the apoptotic pathway activated by antigen induced
negative selection.
Bcl-2 and Negative Selection. We then studied the in-
duction of apoptosis in thymocytes of FTOC from F5/
RAG-12/2 mice, with or without the bcl-2 transgene. Af-
ter negative selection induced by NP68 the level of apop-
tosis in bcl-2 FTOCs was greatly reduced, four- to fivefold,
over those without bcl-2. This demonstrates a strong pro-
tective effect of Bcl-2 on antigen-induced negative selec-
tion. The bcl-2 transgene also caused a threefold reduction
in dexamethasone induced apoptosis. Interestingly, we also
found a moderate protective effect of Bcl-2 on CD95 in-
duced apoptosis, as previously described for primary bcl-2
thymocytes (44). However, in our system this could not be
explained by enhanced survival of bcl-2 transgenic thy-
mocytes (see above). Thus, Bcl-2 can indeed partially in-
hibit CD95-induced apoptosis.
Our data show that Bcl-2 can strongly inhibit antigen-
specific thymic negative selection, whereas Bax, an antago-
nist of Bcl-2, has no effect on negative selection.
Discussion
Apoptosis has been clearly demonstrated to be a key
mechanism in negative selection (7). However, the role of
individual molecules known to regulate apoptosis, in par-
ticular Bcl-2, has remained an area of controversy. Bcl-2
has been shown either to have no effect (10) or to inhibit
(11, 19) superantigen-mediated deletion of autoreactive
thymocytes. Studies on mice doubly transgenic for the
H-Y TCR and bcl-2 have reached different conclusions,
namely that deregulated bcl-2 expression reduces the effi-
ciency of negative selection (20) or has no effect (21). Sim-
ilar types of studies in bcl-XL transgenic mice have con-
cluded that Bcl-XL has no effect on negative selection (22,
23). We sought to address the role of Bcl-2 in T cell devel-
opment and negative selection using MHC class I–restricted
F5 TCR transgenic mice on a RAG-12/2 background to
produce mice whose T cells express a single TCR. We also
studied the effect of a bax transgene within the same con-
Figure 4. Bar chart showing the percentage of apoptosis in FTOCs de-
rived from F5/RAG-12/2 mice plus or minus the bax transgene. The
FTOCs were cultured for 4 d before addition of an apoptotic stimulus
(1) either 10 mM NP68 peptide, 0.5 mM dexamethasone, or 1 mg/ml
anti-Fas antibody (Jo2). After 11 h further culture the FTOCs were har-
vested and stained with CD4, CD8, and 7AAD. The percentage of apop-
tosis as determined by hypodiploid DNA content is shown for sets of in-
dividual thymic lobes with (1) or without (2) apoptotic stimulus. Each
bar represents data from four to six thymic lobes and the error bar repre-
sents their standard deviation. The data shown is for a single complete ex-
periment with similar or identical results to four other independent ex-
periments. (Open bars) F5/RAG-12/2; (striped bars) F5/RAG-12/2/bax.1131 Williams et al.
text, as Bax can act antagonistically of Bcl-2 function and
therefore, might be expected to have opposite functional
consequences.
Expression of the bax transgene in F5/RAG-12/2 mice
reduced the size of the thymus in the context of both se-
lecting and nonselecting MHC. This suggests that Bax can
exert a proapoptotic effect on thymocytes independently of
thymic selection. However, with selecting MHC the num-
ber of CD8 SP thymocytes produced is greatly reduced and
the upregulation of TCR and CD69 expression normally
associated with maturation is also severely reduced. Pre-
cisely the converse is found with the bcl-2 transgene, where
thymus size is increased regardless of MHC. On the select-
ing MHC background, such mice exhibit increased num-
bers of thymocytes with upregulated TCR and CD69, co-
inciding with elevated numbers of CD8 SP thymocytes.
These observations suggest that while Bax and Bcl-2 confer
pro- and antiapoptotic signals, respectively, they also exert
effects on the processes involved in T cell selection. There-
fore, these findings unambiguously confirm previous sug-
gestions about bcl-2 and T cell selection that were compli-
cated by a lack of complete allelic exclusion and the
presence of endogenous TCR rearrangements.
Having established these effects on T cell selection the
question arises as to how Bax and Bcl-2 exert their actions.
Do they act on positive or negative selection separately or
on both processes in opposite directions? We addressed this
question from the perspective of negative selection using
fetal thymic organ culture as our model system. FTOCs
have numerous advantages for this type of study as outlined
above. Our experiments show that upregulated bax expres-
sion while accelerating glucocorticoid-induced apoptosis,
has no effect on negative selection (Fig. 4). However, in-
creased bcl-2 expression leads to substantial inhibition of
negative selection, three- to fourfold, while also inhibiting
glucocorticoid-induced apoptosis and having a marginal ef-
fect on anti-CD95–induced apoptosis (Fig. 5). The mar-
ginal inhibitory effect of bcl-2 on CD95-induced apoptosis
has been noted previously on primary thymocytes in cul-
ture (44) and attributed to a survival effect, i.e., that the bcl-2
transgene simply confers greater viability in culture. How-
ever, as the FTOC system negates the survival effect of
Bcl-2 in culture it would seem that Bcl-2 can partially
inhibit anti-CD95 induced apoptosis. This may be by par-
tially blocking one or more parts of the caspase cascade ac-
tivated by anti-CD95 treatment (reviewed in reference 45).
Overall, our study suggests that Bax has no role in the
apoptotic pathway activated by antigen-induced negative
selection, whereas Bcl-2 can act to block this pathway.
Several important points can be made as a result of this
finding. First, it establishes that a specific apoptosis regula-
tory molecule, Bcl-2, can also regulate negative selection.
It remains to be seen whether apoptosis regulatory mole-
cules can similarly influence positive selection and this may
be directly measurable using an FTOC approach. For in-
stance, the bax transgene leads to a decline in mature SP T
cell production but does not increase negative selection.
Therefore, it may act to decrease positive selection, as sug-
gested by the decreased expression of CD69 on intermedi-
ate CD4loCD8hi thymocytes of bax transgenic mice. Thus,
Bax may directly inhibit positive selection or reduce its ef-
ficiency indirectly by reducing the viability of thymocytes
(12), effectively reducing the number of thymocytes avail-
able for positive selection. In contrast the bcl-2 transgene
leads to an increase in the number of intermediate CD69hi
CD4loCD8hi and mature CD8 SP thymocytes as well as an
increase in the total number of thymocytes in the presence
of selecting and nonselecting MHC molecules. These re-
sults suggest that Bcl-2 increases the efficiency of positive
Figure 5. Bar chart showing the percentage of apoptosis in FTOCs de-
rived from F5/RAG-12/2 mice plus or minus the bcl-2 transgene. The
FTOCs were cultured for 4 d before addition of an apoptotic stimulus
(1) either 10 mM NP68 peptide, 0.5 mM dexamethasone, or 1 mg/ml
anti-Fas antibody (Jo2). After 11 h further culture the FTOCs were har-
vested and stained with CD4, CD8, and 7AAD. The percentage apoptosis
as determined by hypodiploid DNA content is shown for sets of individ-
ual thymic lobes with (1) or without (2) apoptotic stimulus. Each bar
represents data from four to six thymic lobes. The data shown is for a sin-
gle complete experiment with similar or identical results to four other in-
dependent experiments. (Open bars) F5/RAG-12/2; (striped bars) F5/
RAG-12/2/bcl-2.
Figure 6. A model representing the properties of Bax and Bcl-2 in T
cell selection. Bax and Bcl-2 have antagonistic effects on positive selection
and death by neglect. However, Bax has no effect on negative selection,
whereas Bcl-2 can inhibit it. This implies that an unidentified member of
the Bcl-2 family can antagonize the effect of Bcl-2 on negative selection.1132 Action of Bax and Bcl-2 on T Cell Selection
selection. Thus, in thymocytes Bax and Bcl-2 appear to be
functionally antagonistic in the decision between death by
neglect and positive selection, whereas Bcl-2 acts indepen-
dently of Bax in inhibiting negative selection. A model
summarizing these properties of Bax and Bcl-2 is shown in
Fig. 6. Although Bax does not have a direct role in nega-
tive selection, it is very likely that other proapoptotic
members of the Bcl-2 family do, in order to counteract
Bcl-2 (Fig. 6). Therefore, a further task will be to deter-
mine which ones act in negative selection. Another aspect
of the data is that whereas Bcl-2 has a strong inhibitory ef-
fect on negative selection it has very little effect on CD95-
induced apoptosis. This would support the idea that the
CD95 pathway has no great role in thymic negative selec-
tion (46, 47) rather than the view that CD95 modulation is
an integral part of the negative selection of thymocytes
(48).
Our study establishes peptide antigen-induced deletion
in FTOCs as a model system to directly study apoptosis as a
result of negative selection. Due to the intrinsically negligi-
ble levels of background cell death in the system it is also a
very useful method to study other apoptotic stimuli in T
cells. We hope to further develop this method to study
apoptosis regulatory molecules in positive selection.
Recently, it has been proposed that, although Bax and
Bcl-2 can form heterodimers and act to antagonize each
other’s function, they also regulate apoptosis independently
of one another (30, 49). We further validate this hypothesis
by showing Bax and Bcl-2 do not have reciprocal effects
within the same system. Bax and Bcl-2 exert their opposing
effects on glucocorticoid-induced apoptosis, whereas Bcl-2
inhibits negative selection and Bax has no effect. Hence,
Bax and Bcl-2 can function independently of their physical
interaction with each other in the cell (30).
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